Orion Ophthalmology LLC has a total of 22 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are REGENACY PHARMACEUTICALS LLC, PMV PHARMACEUTICALS INC and DAHL RUSSELL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Singapore | 2 | |
#10 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Gomez Robert | 18 |
#2 | Oballa Renata Marcella | 16 |
#3 | Powell David Andrew | 16 |
#4 | Ding Jinyue | 11 |
#5 | Epifanov Maxim | 8 |
#6 | Sheng Tao | 7 |
#7 | Roppe Jeffrey Roger | 6 |
#8 | Seiders Thomas Jon | 6 |
#9 | Chen Austin Chih-Yu | 5 |
#10 | David Andrew Powell | 4 |
Publication | Filing date | Title |
---|---|---|
EP3472151A1 | Carbocyclic prolinamide derivatives | |
AU2017282653A1 | Aliphatic prolinamide derivatives | |
KR20190011322A | Heterocyclic proline amide derivatives |